Reversal of oxidative stress in endothelial cells by controlled release of adiponectin

Journal of Controlled Release

Volumn 130, Issue 3, 2008, Pages 234-237

  Mossalam, Mohanad ^a   Jeong, Ji Hoon ^a,b   Abel, E Dale ^c   Kim, Sung Wan ^a,d   Kim, Yong Hee ^a,d  

^a UNIVERSITY OF UTAH   (United States)

^b Sungkyunkwan University   (South Korea)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d Hanyang University   (South Korea)

Author keywords

Adiponectin; Controlled release; Endothelial cells; Oxidative stress

Indexed keywords

ABS RESINS; BLOOD VESSEL PROSTHESES; CELL CULTURE; COLLOIDS; FETAL MONITORING; GELATION; GLUCOSE; OXYGEN; POLYMERS; SELF ASSEMBLY;

ADIPONECTIN; CONTROLLED RELEASE; OXIDATIVE STRESS;

ENDOTHELIAL CELLS;

ADIPONECTIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCOSE; POLYMER; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG EFFICACY; ENDOTHELIUM CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADIPONECTIN; ANIMALS; CATTLE; CELLS, CULTURED; CYCLIC AMP; DELAYED-ACTION PREPARATIONS; ENDOTHELIAL CELLS; GLUCOSE; LACTIC ACID; MICE; OXIDATIVE STRESS; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; REACTIVE OXYGEN SPECIES;

EID: 50949114724     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2008.06.009     Document Type: Article

References (26)

1. Nathan D.M., Cleary P.A., Backlund J.Y., Genuth S.M., Lachin J.M., Orchard T.J., Raskin P., and Zinman B. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353 (2005) 2643-2653
2. Kuroki T., Isshiki K., and King G.L. Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications. J. Am. Soc. Nephrol. 14 (2003) S216-S220
3. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54 (2005) 1615-1625
4. Ohara Y., Peterson T.E., and Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91 (1993) 2546-2551
5. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., and Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97 (1996) 1916-1923
6. Hattori Y., Kawasaki H., Abe K., and Kanno M. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol. 261 (1991) H1086-H1094
7. van der Loo B., Labugger R., Skepper J.N., Bachschmid M., Kilo J., Powell J.M., Palacios-Callender M., Erusalimsky J.D., Quaschning T., Malinski T., Gygi D., Ullrich V., and Luscher T.F. Enhanced peroxynitrite formation is associated with vascular aging. J. Exp. Med. 192 (2000) 1731-1744
8. Laurindo F.R., de Souza H.P., Pedro Mde A., and Janiszewski M. Redox aspects of vascular response to injury. Methods Enzymol. 352 (2002) 432-454
9. Park J.H., Lee M., and Kim S.W. Non-viral adiponectin gene therapy into obese type 2 diabetic mice ameliorates insulin resistance. J. Control. Release 114 (2006) 118-125
10. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
11. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., and Tataranni P.A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86 (2001) 1930-1935
12. Motoshima H., Wu X., Mahadev K., and Goldstein B.J. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem. Biophys. Res. Commun. 315 (2004) 264-271
13. Costacou T., Zgibor J.C., Evans R.W., Otvos J., Lopes-Virella M.F., Tracy R.P., and Orchard T.J. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 48 (2005) 41-48
14. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., and Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114 (2004) 1752-1761
15. Nakanishi S., Yamane K., Kamei N., Nojima H., Okubo M., and Kohno N. A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metabolism 54 (2005) 194-199
16. Ouedraogo R., Wu X., Xu S.Q., Fuchsel L., Motoshima H., Mahadev K., Hough K., Scalia R., and Goldstein B.J. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 55 (2006) 1840-1846
17. Kissel T., Li Y., Gorich S., Volland C., and Koneberg R. Parenteral protein delivery systems using biodegradable ABA-block-copolymers. J. Control. Release 39 (1996) 315-326
18. Duvvuri S., Janoria K.G., and Mitra A.K. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir. J. Control. Release 108 (2005) 282-293
19. Chang C.W., Choi D., Kim W.J., Yockman J.W., Christensen L.V., Kim Y.H., and Kim S.W. Non-ionic amphiphilic biodegradable PEG-PLGA-PEG copolymer enhances gene delivery efficiency in rat skeletal muscle. J. Control. Release 118 (2007) 245-253
20. Zentner G.M., Rathi R., Shih C., McRea J.C., Seo M.H., Oh H., Rhee B.G., Mestecky J., Moldoveanu Z., Morgan M., and Weitman S. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J. Control. Release 72 (2001) 203-215
21. Kissel T., Li Y., and Unger F. ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins. Adv. Drug Deliv. Rev. 54 (2002) 99-134
22. Chen S., Pieper R., Webster D.C., and Singh J. Triblock copolymers: synthesis, characterization, and delivery of a model protein. Int. J. Pharm. 288 (2005) 207-218
23. Laurent A., Nicco C., Chereau C., Goulvestre C., Alexandre J., Alves A., Levy E., Goldwasser F., Panis Y., Soubrane O., Weill B., and Batteux F. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res. 65 (2005) 948-956
24. Wu X., Mahadev K., Fuchsel L., Ouedraogo R., Xu S.Q., and Goldstein B.J. Adiponectin suppresses IkB kinase activation induced by tumor necrosis factor-{alpha} or high glucose in endothelial cells: role of cAMP and AMP kinase signaling. Am. J. Physiol: Endocrinol. Metab. (2007) E1836-E1844
25. Wong E.T., Alsop D., Lee D., Tam A., Barron L., Bloom J., Gautam S., and Wu J.K. Cerebrospinal fluid matrix metalloproteinase-9 increases during treatment of recurrent malignant gliomas. Cerebrospinal Fluid Res. 5 (2008) 1
26. Aronson D. Hyperglycemia and the pathobiology of diabetic complications. Adv. Cardiol. 45 (2008) 1-16